1960P Differential induction of gene expression may explain differences in reported adverse event profiles between the FGFR-inhibitors derazantinib and erdafitinib: An analysis in safety relevant normal tissues from urothelial cancer (UC) patient-derived mouse xenograft (PDX) models
| Autor: | McSheehy, P., Guo, J., Beebe, K., Eisner, J.R., Anderson, S., Braun, S., Engelhardt, M., Kellenberger, L., Lane, H., Milburn, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S1103-S1104 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|